Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells

Journal of the National Cancer Institute

Volumn 91, Issue 19, 1999, Pages 1647-1653

  Kitazono, Masaki ^b   Sumizawa, Tomoyuki ^b   Takebayashi, Yuji ^b   Chen, Zhe Sheng ^b   Furukawa, Tatsuhiko ^b   Nagayama, Shuichi ^b   Tani, Ayako ^b   Takao, Sonshin ^b   Aikou, Takashi ^b   Akiyama, Shin Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GRAMICIDIN D; LUNG RESISTANCE PROTEIN; PACLITAXEL; VINCRISTINE;

ARTICLE; CANCER RESISTANCE; CELL CULTURE; CELL LEVEL; CELL TRANSFORMATION; COLON CANCER; DRUG ACCUMULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033530286     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.19.1647     Document Type: Article

References (29)

1. Wittes RE, Goldin A. Unresolved issues in combination chemotherapy. Cancer Treat Rep 1986;70:105-25.
2. Gottesman MM, Pastan I. The multidrug transporter: a double-edged sword. J Biol Chem 1988;263:12163-6.
3. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-4.
4. Loe DW, Deeley RG, Cole SP. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 1996;32A:945-57.
5. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996;56:988-94.
6. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993;53: 1475-9.
7. Scheffer GL, Wijingaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995;1:578-82.
8. Rome LH, Kedersha NL, Chugani DC. Unlocking vaults: organelles in search of a function. Trends In Cell Biol 1991;1:47-50.
9. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Science 1993;106(Pt 1):23-9.
10. Schuurhuis GJ, Broxterman HJ, de Lange JH, Pinedo HM, van Heijningen TH, Kuiper CM, et al. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer 1991;64:857-61.
11. Dietel M, Arps H, Lage H, Niedorf A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 1990;50:6100-6.
12. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, et al. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J Biol Chem 1989;264:18031-40.
13. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 1993;53:3658-61.
14. 4 and chemotherapeutic agents in membrane vesicles. J Biol Chem 1996;271:9675-82.
15. Akiyama S, Fojo AT, Hanover JA, Pastan IH, Gottesman MM. Isolation and genetic characterization of human KB cells resistant to multiple drugs. Somat Cell Genet 1985;11:117-26.
16. Sumizawa T, Chuman Y, Sakamoto H, Iemura K, Almquist KC, Deeley RG, et al. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing doxorubicin, cepharanthine, and mezerein. Somat Cell Mol Genet 1994;20:423-35.
17. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG, et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54: 357-61.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
19. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-42.
20. Newmeyer DD, Wilson KL. Egg extracts for nuclear import and nuclear assembly reactions. Methods Cell Biol 1991;36:607-34.
21. Kickhoefer VA, Rajavel KS, Scheffer GL, Dalton WS, Scheper RJ, Rome LH. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 1998;273:8971-4.
22. Bates SE, Currier SJ, Alvarez M, Fojo AT. Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry 1992;31:6366-72.
23. Gottesman MM, Hrycyna CA, Schoenlein PV, German UA, Pastan I. Genetic analysis of the multidrug transporter. Annu Rev Genet 1995;29: 607-49.
24. Ikeda S, Sugita M, Yoshimura A, Sumizawa T, Douzono H, Nagata Y, et al. Aspergillus species strain M39 produces two naphtho-α-pyrones that reverse drug resistance in human KB cells. Int J Cancer 1990;45:508-13.
25. Sumizawa T, Chen ZS, Chuman Y, Seto K, Furukawa T, Haraguchi M, et al. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. Mol Pharmacol 1997;51: 399-405.
26. Izquierdo MA, Shoemaker RH, Flens MJ, Scheffer GL, Wu L, Prather TR, et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996;65:230-7.
27. Hamill DR, Suprenant KA. Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport. Dev Biol 1997;190:117-28.
28. Izquierdo MA, van der Zee AG, Vermorken J, van der Valk P, Belien JA, Giaccone G, et al. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 1995;87:1230-6.
29. List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996; 87:2464-9.